Drugs / Fecal microbial transplant
Fecal microbial transplant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03152188 | Jun 2017 → Nov 2018 | cirrhosis of liver, hepatic encephalopathy | Virginia Commonwealth University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal microbial transplant | “Fecal microbial transplant (FMT) enemas postantibiotics are safe, but the effect of FMT without antibiotics using the capsular route requires investigation.” PMID 31038755 ↗ Jun 2019 |
| Known as | Fecal Microbiota Transplantation | “performing this Fecal Microbiota Transplantation (FMT) by cross-referencing of their drug master file.” NCT03152188 ↗ |
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03152188 ↗ |
| Modality | Other / unclassified | “Fecal Microbiota Transplantation (FMT)” NCT03152188 ↗ |
| Route | Oral | “oral capsular fecal microbial transplant (FMT)” PMID 31751317 ↗ Dec 2019 |